TrialFrontiers in immunology2025

Trends in allergen-reactive CRTH2+ T cells and TARC associated with successful outcomes in a phase 2 cashew oral immunotherapy study.

Sayantani B Sindher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.